Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 21, 2017
Pharmacy Choice - Pharmaceutical News - ABL Awarded BARDA Contract to Fill Live Virus-Based Medical Countermeasures - September 21, 2017

Pharmacy News Article

 4/21/17 - ABL Awarded BARDA Contract to Fill Live Virus-Based Medical Countermeasures

By a News Reporter-Staff News Editor at Drug Week ABL, Inc. (ABL), a global contract research and manufacturing service provider to the U.S. Government and biopharmaceutical industry, announced it has been awarded a five-year, indefinite delivery/indefinite quantity (ID/IQ) contract #HHSO100201600019I entitled "Respiratory Illness Live Virus Fill/Finish Services" by the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) (see also ABL, Inc.).

The contract has a maximum ordering amount of $50 million and is part of a multiple award network to provide fill/finish capabilities for live virus-based medical countermeasure (MCM) product development towards licensure. ABL will utilize its GMP facilities located in Rockville, MD and Strasbourg, France, each site staffed with manufacturing, bioanalytical and quality assurance teams with extensive experience producing vaccine, therapeutic and diagnostic products.

"We are very excited to be supporting BARDA and ASPR for the rapid development and manufacture of vaccines and therapeutics against potential pandemic and emerging disease targets," said Dr. Thomas VanCott, President and CEO of ABL. "ABL provides bulk and filling capabilities specifically designed to handle live virus products, and with facilities in Europe and the U.S., we are ideally positioned to meet BARDA's MCM requirements."

ABL's fill and finish drug manufacturing capabilities meet U.S. FDA and European GMP requirements for a wide variety of live/vectored products at pilot, clinical, and commercial scales. Our infrastructure and expertise provides BARDA with the rapid response times and flexible resources required during a public health emergency. Our comprehensive services ranging from development to GMP to regulatory support, means that our clients can be assured of a smooth transition as their product advances through preclinical and clinical phases with the highest level of quality and technical expertise. About ABL ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing therapeutics, vaccines and other biologic products. ABL maintains GMP facilities meeting U.S. and European regulatory standards, providing process and assay development, cGMP manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC bioanalytical testing. Our U.S. and European immunological and molecular laboratories support clients' preclinical and GCLP clinical sample processing and testing needs. ABL is a part of the Institut Merieux, a group of companies dedicated to developing translational science for better patient care globally.

For more information visit www.ablinc.com or contact us. About BARDA The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. BARDA develops and procures needed medical countermeasures, including vaccines, therapeutics, diagnostics, and non-pharmaceutical countermeasures, against a broad array of public health threats, whether natural or intentional in origin. View source version on businesswire.com: http://www.businesswire.com/news/home/20170405005860/en/

Keywords for this news article include: ABL Inc., Vaccines, Immunization, Therapeutics, Public Health, Biological Products, Government Agencies Offices and Entities.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Last Chance
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415